- DocumentoImmunomodulation by thalidomide and thalidomide analoguescaricato da
lptscsi
- DocumentoThalidomide and Celecoxib for severe COVID-19 Pneumoniacaricato da
lptscsi
- DocumentoSingle-Dose_Pharmacokinetics_of_Thalidom.pdfcaricato da
lptscsi
- DocumentoThalidomide combined with low-dose glucocorticoid in the treatment of COVID-19caricato da
lptscsi
- DocumentoLepra_reactions.pdfcaricato da
lptscsi
- DocumentoPhase I Study of an Immunomodulatory Thalidomide Analog, CC-4047, in Relapsed or Refractory Multiple Myelomacaricato da
lptscsi
- DocumentoPomalidomide is nonteratogenic in chicken and zebrafish embryos and nonneurotoxic in vitrocaricato da
lptscsi
- DocumentoLEPRA_Analog.pdfcaricato da
lptscsi
- DocumentoLEPRA_Analog.pdfcaricato da
lptscsi
- DocumentoDesign, Synthesis, and Biological Evaluation of Novel Non-Piperazine Analogues of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as Dopamine Transporter Inhibitorscaricato da
lptscsi
- DocumentoThe unique psychostimulant profile of modafinilcaricato da
lptscsi
- Documentobcsj.56.280caricato da
lptscsi